TiLV Disease – Tilapia lake virus is a newly emerging virus that is associated with significant moralities in farmed Tilapia. With cases reported across Africa, Asia and South America, the virus represents a huge risk to the global Tilapia industry, whose 2015 production was valued at USD 9.8 billion.
Kovax developed a vaccine to this disease.
Safe and efficient vaccine – Fish vaccinated with TV1 Vaccine showed no sign of disease and were comparable in behavior to the unchallenged placebo group. Mortality level of 2.9% (a single fish) was observed throughout the observation period.